Introduction: Package Inserts (PIs) refers to officially specified document that accompanies a drug for relevant, updated and unbiased information for rational drug use based on regulatory guidelines as per section 6.2 and 6.3 of schedule D of Indian Drug and cosmetic Act 1945. But some studies had shown non-uniformity with suboptimal level of informations which frequently can lead to medication errors. Hence this study was conducted to evaluate the completeness of PIs. Aim: To critically evaluate package inserts of allopathic medicines. Material and Methods: 100 allopathic drug PIs were collected from pharmacies in Rohtak and were checked for the presence of each heading as per schedule D criteria, followed by scrutiny of the information included under the heading. Indian guidelines were also compared with US FDA guidelines for PIs. Scoring of package inserts: The informations were evaluated for completeness and scored as 1 if present otherwise scored as zero for no information or partial information. Scores for each heading were calculated by totaling the scores of all the package inserts. The total scores were expressed as absolute numbers and percentages. Results: On an average PIs analyzed for the completeness of the criteria scored 10 (Mean SD = 9.732.48) out of 16. Absence of common layout and headings caused inconvenience. In comparison to US FDA guidelines it lacked, disclaimer statement, boxed warning, revision date, approval date, toll-free number etc. Conclusion: PIs dont seem to be serving effectively because of multiple deficiencies like completeness, uniformity, absence of headings.
Fuchs J, Hippius M, Schaefer M. Analysis of German package inserts. Int J Clin Pharmacol Ther 2006; 44: 8-13.
Ved JK. Package Inserts in India: Need for a Revision. Int J of Pharma Sci and Res 2010; 1(11): 454-6.
Amran S, Ahmed M, Shaheen SM, Morshed SN, Khandakar J, Rahman M, et al. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh. Pak J Pharm Sci 2007; 20: 327-32.
Joubert PH, Skene D. Attitudes of private medical practitioners towards package inserts and other drug information sources. S Afr Med J 1984; 66: 306-7.
Suleh AB, Hisham SAA, Othman AG, Khal A, Mohammed JMS. Public Attitude towards Drug Technical Package Inserts in Saudi Arabia. J Pharm Technol 2003; 19: 209-18.
Rajan MS, Khan SA, Thiyagu R, Rao PG. Information seeking behaviour of clinicians in a semi urban town in southern India. J Clin Diag Res 2008; 2: 1069-73.
Prosser H, Almond S, Walley T. Influences on GPs′ decision to prescribe new drugs-the importance of who says what. Fam Pract 2003; 20: 61-8.
Saha L, Pandhi P, Malhotra S, Sharma N. Adverse drug event (ADE) related medical emergency department visits and hospital admissions: A prospective study from a north Indian referral hospital. J Clin Diag Res 2008; 2: 600-4.
Wong YL. Adverse effects of pharmaceutical excipients in drug therapy. Ann Acad Med Singapore 1993; 22: 99-102.
Shivkar YM. Clinical information in drug package inserts in India. J Postgrad Med 2009; 55: 104-7.
Zaghi D, Maibach HI. Survey of safety and efficacy information in drug inserts for topical prescription medications. Am J Clin Dermatol 2007; 8: 43-6.
Dikshit RK, Dikshit ND. What information is available on request from drug advertisers. BMJ 1996; 313: 855-6.
Lal A, Sethi A. Drug package inserts in India. Ann Pharmacother 1996; 30: 1041.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article